Ulcerative Colitis Market Analysis, Trends, Size, Share, Growth & Forecast 2018 - 2026

                                                                            
The mucosal lining of the colon is affected by ulcerative colitis, a chronic idiopathic inflammatory bowel disease (IBD) affecting the gastrointestinal system.

             Ulcerative Colitis Market


The mucosal lining of the colon is affected by ulcerative colitis, a chronic idiopathic inflammatory bowel disease (IBD) affecting the gastrointestinal system. It is most common in people between the ages of 15 and 30. Along with Crohn's disease, ulcerative colitis is one of the two main kinds of IBD. Unlike Crohn's disease, which can affect any region of the digestive tract, ulcerative colitis usually affects just the large intestine. The exact aetiology of the sickness has yet to be discovered. According to the existing evidence, it could be the outcome of an overreactive immune response to normal bacteria and other chemicals in the gastrointestinal system. Due to inflammation and the formation of open sores (ulcers) in the large intestine (colon) and rectum, ulcerative colitis causes abdominal pain and bloody diarrhoea.

The rising prevalence of ulcerative colitis disease, which affects millions of individuals worldwide, is driving the expansion of the global Ulcerative Colitis Market. Furthermore, significant R&D and investment by key players in the development of innovative medicines for UC therapy, as well as an increase in government and non-government organisations funding biologics research, are fueling market expansion. However, the market is restrained by the expiration of drug patents and strict government restrictions governing biosimilar approval. Unmet needs in the treatment of UC present significant prospects for market expansion.

Market Segmentation:

Global Market by Drug Type
  • Infliximab
  • Golimumab
  • Adalimumab
  • Vedolizumab
  • Mesalamine
  • Budesonide
  • Balsazide

Global Market by Dosage Form
  • Parenteral
  • Oral

Global Market by Geography
  • North America
  • Europe
  • APAC
  • Latin America
  • Middle East
  • Africa
The market is growing because to the rising prevalence of ulcerative colitis around the world. The industry is also benefiting from increased spending on research and development capabilities to create innovative treatments. The expansion of the ulcerative colitis therapy industry is also being fueled by increased efforts by governmental and non-governmental organisations to do biologics research.

Some major companies playing leading role in ulcerative colitis market are AbbVie Inc., Hospira, Celltrion Healthcare, Johnson and Johnson, F. Hoffmann-La Roche AG, Warner Chilcott, Janssen Pharmaceuticals Inc. and Takeda Pharmaceuticals Company Ltd.

Comments

Post a Comment

Popular posts from this blog

Flavors and Fragrances Market: A Comprehensive Analysis of Current Trends and Future Outlook

Image
  Flavors and Fragrances Market Introduction: The global flavors and fragrances market has witnessed remarkable growth in recent years, driven by increasing consumer preferences for enhanced sensory experiences in various industries. Flavors and fragrances play a vital role in food and beverages, personal care products, household products, and the pharmaceutical industry. This report provides an in-depth analysis of the flavors and fragrances market, highlighting key trends, market dynamics, and future prospects. Market Overview: The flavors and fragrances market has experienced substantial growth, with a projected CAGR of X% from 2023 to 2028. The market is primarily driven by rising disposable incomes, urbanization, and changing consumer lifestyles. Key market players are continually investing in research and development activities to introduce innovative flavors and fragrances that cater to evolving consumer demands. Segmentation and Key Market Players: The market can...
Read more

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the...
Read more

Global Orthopedic Imaging Market Size By Product, By Indication, By End User, Analysis And Forecast 2027

Image
                              Orthopedic Imaging Market Medical imaging in orthopaedics allows doctors to examine the interior architecture of the body non-invasively to aid in the diagnosis of a medical disease. Medical imaging technologies detect and track illnesses and injuries by providing pictures that represent the interior anatomical features of the patient's body. These gadgets are utilised as a knowledge tool to assist clinicians in determining the condition and its response to therapy. Orthopedic medical imaging provides clinicians with dependable, accessible, and high-quality imaging, which is an important criterion for medical decision-making and may lessen the need for surgical operations. Increased incidences of bone fracture trauma due to falls, motor vehicle accidents, or sports injuries necessitate prompt medical attention, which orthopaedic medical imaging systems may deliver. According to the ...
Read more